TNFRSF17 as a complementary biomarker to PD-L1 for predicting the response to immunotherapy in urothelial bladder cancer

• Jiawen Chen,

  Roles Data curation, Investigation, Methodology, Visualization, Writing – original draft

  Affiliation Department of Urology, Xiangya Hospital, Central South University, China

  ⨯
• Bingsheng Li,

  Roles Conceptualization, Data curation, Funding acquisition

  Affiliation Department of Urology, Xiangya Hospital, Central South University, China

  ⨯
• Yu Gan ,

  Roles Funding acquisition, Methodology, Supervision, Validation, Writing – review & editing

  * E-mail: ganyu@csu.edu.cn (YG); lipan90med@gmail.com (PL)

  Affiliation Department of Urology, Xiangya Hospital, Central South University, China

  ⨯
• Pan Li

  Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Software, Supervision, Validation, Visualization, Writing – review & editing

  * E-mail: ganyu@csu.edu.cn (YG); lipan90med@gmail.com (PL)

  Affiliations Department of Pathology, Xiangya Hospital, Central South University, China, Institute of Pathology, Medical Faculty, Ludwig-Maximilians-University Munich, Munich, Germany

  https://orcid.org/0000-0001-5942-0083

  ⨯